Abstract

Introduction: Lymphedema is the most common secondary complication that people with breast cancer face.Characterized by the appearance of new growth. The new growth usually takes the shape of a lump which isfrequently referred to as a neoplasm. Lymphedema in women who have had a mastectomy has the potential tobecome a chronic and progressive disorder. It is necessary to determine the impact of each strategy. The goal ofthis research was to investigate and evaluate the best treatment for lymphedema secondary to breast cancer.Method: This study included 30 women with lymphedema caused by breast cancer. They were assigned to oneof three groups. Group A (n=10) received complete decongestive therapy. Group B (n=10) received pneumaticcompression, while Group C (n=10) received faradism under pressure. Subjects from all three groups were askedto come to the department three times per week for two months. Patients girth and pain intensity were measuredpre and post treatment.Conclusion: As a result, the researchers concluded that in patients with mild lymphedema, comprehensivedecongestive therapy was more effective.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.